The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 1 , Pages 216-224.e4 , July 2010

In vitro functional comparison of therapeutically relevant human vasculogenic progenitor cells used for cardiac cell therapy

  • Yan Zhang, MD, MSc

      Affiliations

    • Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
    • Y. Zhang and S. Wong contributed equally to this work.
    • ,
  • Serena Wong, BSc

      Affiliations

    • Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
    • Y. Zhang and S. Wong contributed equally to this work.
    • ,
  • Jessica Laflèche, BSc

      Affiliations

    • Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
    • ,
  • Suzanne Crowe

      Affiliations

    • Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    • ,
  • Thierry G. Mesana, MD, PhD

      Affiliations

    • Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    • ,
  • Erik J. Suuronen, PhD

      Affiliations

    • Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
    • Corresponding Author InformationAddress for reprints: Marc Ruel, MD, MPH, and Erik J. Suuronen, Division of Cardiac Surgery, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, Ontario, K1Y 4W7, Canada.
    • ,
  • Marc Ruel, MD, MPH

      Affiliations

    • Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
    • Corresponding Author InformationAddress for reprints: Marc Ruel, MD, MPH, and Erik J. Suuronen, Division of Cardiac Surgery, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, Ontario, K1Y 4W7, Canada.

Received 30 June 2009 ,Revised 15 October 2009 ,Accepted 3 November 2009.

References 

  1. Ruel M, Song J, Sellke FW. Protein-, gene-, and cell-based therapeutic vasculogenesis for the treatment of myocardial ischemia. Mol Cell Biochem. 2004;264:119–131
  2. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103:1204–1219
  3. Suuronen EJ, Price J, Veinot JP, Ascah K, Kapila V, Guo XW, et al. Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function. J Thorac Cardiovasc Surg. 2007;134:1249–1258
  4. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 2003;361:45–46
  5. Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;11:2198–2202
  6. Zhang Y, Thorn S, DaSilva JN, Lamoureux M, deKemp RA, Beanlands RS, et al. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstration by ex vivo radionuclide cell labeling and in vivo tracking with positron emission tomography. Circ Cardiovasc Imaging. 2008;1:197–204
  7. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952–958
  8. Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B, et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg. 2007;133:717–725
  9. Masuda H, Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res. 2003;58:390–398
  10. Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, Rodrigo M, et al. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2005;25:296–301
  11. Hill JM, Syed MA, Arai AE, Powell TM, Paul JD, Zalos G, et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol. 2005;46:1643–1648
  12. Suuronen EJ, Wong S, Kapila V, Waghray G, Whitman SC, Mesana TG, et al. Generation of CD133(+) cells from CD133(-) peripheral blood mononuclear cells and their properties. Cardiovasc Res. 2006;70:126–135
  13. Ruel M, Suuronen EJ, Song J, Kapila V, Gunning D, Waghray G, et al. Effects of off-pump versus on-pump coronary artery bypass grafting on function and viability of circulating endothelial progenitor cells. J Thorac Cardiovasc Surg. 2005;130:633–639
  14. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106:3009–3017
  15. Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation. 2005;112(suppl):I178–I183
  16. Suuronen EJ, Veinot JP, Wong S, Kapila V, Price J, Griffith M, et al. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation. 2006;114(suppl):I138–I144
  17. Shantsila E, Watson T, Lip GY. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol. 2007;49:741–752
  18. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, et al. Human CD34 + AC133 + VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35:1109–1118
  19. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of vasculogenic cytokines and matrix metalloproteinases. Circulation. 2005;112:1618–1627
  20. Ruel M, Laham RJ, Parker JA, Post MJ, Ware JA, Simons M, et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg. 2002;124:28–34
  21. Copland I, Sharma K, Lejeune L, Eliopoulos N, Stewart D, Liu P, et al. CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization. Exp Hematol. 2008;36:93–103
  22. Annabi B, Lee YT, Turcotte S, Naud E, Desrosiers RR, Champagne M, et al. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells. 2003;21:337–347
  23. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109:1615–1622
  24. Matsuura K, Honda A, Nagai T, Fukushima N, Iwanaga K, Tokunaga M, et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest. 2009;119:2204–2217
  25. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation. 2002;105:732–738

 Supported by the Canadian Institutes of Health Research (to Drs Ruel and Suuronen, grant MOP-77536), by the Canadian Foundation for Innovation (to Dr Ruel, award 7346), and by the Heart and Stroke Foundation of Canada Doctoral Research Award (to Dr Zhang).

 Disclosures: None.

PII: S0022-5223(09)01471-8

doi: 10.1016/j.jtcvs.2009.11.016

The Journal of Thoracic and Cardiovascular Surgery
Volume 140, Issue 1 , Pages 216-224.e4 , July 2010

Article Tools

* Image Usage & Resolution